Chun-Tao Wu
Overview
Explore the profile of Chun-Tao Wu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
805
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Zhang W, Wang W, Gao H, Xu S, Li S, Li T, et al.
J Clin Endocrinol Metab
. 2020 Apr;
105(7).
PMID: 32285127
Objective: This study retrospectively characterized the immune infiltrating profile in nonfunctional pancreatic neuroendocrine tumors (NF-PanNETs). Methods: Tumor tissues from the 109-patient Fudan cohort and a 73-patient external validation set were...
12.
Xu S, Li S, Xu H, Li H, Wu C, Wang W, et al.
World J Gastroenterol
. 2020 Mar;
26(8):828-838.
PMID: 32148380
Background: Systemic inflammation and nutrition status play an important role in cancer metastasis. The combined index of hemoglobin, albumin, lymphocyte, and platelet (HALP), consisting of haemoglobin, albumin, lymphocytes, and platelets,...
13.
Xu J, Wang W, Zhang W, Xu H, Gao H, Zhang S, et al.
J Cancer
. 2019 Aug;
10(17):4123-4131.
PMID: 31417657
: Pancreatic ductal adenocarcinoma (PDAC) progression is mediated by mutations in driver genes and a complex stroma that is mainly dependent on the Sonic hedgehog (Shh) signaling pathway. However, the...
14.
Li H, Zhang S, Xu H, Wang W, Li S, Li T, et al.
J Cancer
. 2019 Jul;
10(12):2670-2678.
PMID: 31258775
: SRPX2 and RAB31 play important roles in tumorigenesis and metastasis; however, their prognostic value in pancreatic cancer remains unclear. This study aimed to investigate the potential interactions and effects...
15.
Zhang S, Li H, Wang W, Jin W, Xu J, Xu H, et al.
Eur J Surg Oncol
. 2018 Nov;
45(5):769-775.
PMID: 30416079
Introduction: Arpin (Arp2/3 complex inhibitor), a novel protein found in 2013, plays a pivotal role in cell motility and migration. However, the prognostic value of Arpin in pancreatic ductal adenocarcinoma...
16.
Jin W, Xu H, Zhang S, Li H, Wang W, Gao H, et al.
Ann Surg Oncol
. 2018 Oct;
26(2):635-643.
PMID: 30374923
Background: Tumor-infiltrating neutrophils (TINs) indicate poor prognosis for patients with pancreatic ductal adenocarcinoma (PDAC). Activated neutrophils can generate neutrophil extracellular traps (NETs). Little is known about the presence and prognostic...
17.
Qi Z, Xu H, Zhang S, Xu J, Li S, Gao H, et al.
J Cancer
. 2018 Oct;
9(18):3417-3426.
PMID: 30271504
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal types of cancer. The 5-year survival rate for PDAC remains low because it is always diagnosed at an advanced stage...
18.
Zhang S, Yao L, Wang W, Xu J, Xu H, Jin W, et al.
Ann Surg Oncol
. 2018 Sep;
25(13):3984-3993.
PMID: 30171511
Background: Platelets are believed to promote tumor growth and metastasis in several tumor types. The prognostic role of blood platelets in pancreatic ductal adenocarcinoma (PDAC) remains controversial, and the prognostic...
19.
Li S, Xu H, Wu C, Wang W, Jin W, Gao H, et al.
Angiogenesis
. 2018 Sep;
22(1):15-36.
PMID: 30168025
Pancreatic cancer is one of the most lethal malignancies worldwide. Although the standard of care in pancreatic cancer has improved, prognoses for patients remain poor with a 5-year survival rate...
20.
Xu H, Li S, Wu C, Qi Z, Wang W, Jin W, et al.
Pancreatology
. 2018 Aug;
18(6):671-677.
PMID: 30153903
Objective: To evaluate the prediction of benefits from adjuvant chemoradiotherapy by postoperative serum CA19-9, CA125 and CEA. Methods: The relations between benefits from adjuvant chemoradiotherapy and levels of postoperative serum...